[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant

J Lopez Bernal, N Andrews, C Gower… - … England Journal of …, 2021 - Mass Medical Soc
Abstract Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[PDF][PDF] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower, E Gallagher… - vaccine, 2021 - researchgate.net
BACKGROUND The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[PDF][PDF] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower, E Gallagher… - vaccine, 2021 - iacld.com
BACKGROUND The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[PDF][PDF] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower, E Gallagher… - vaccine, 2021 - mai68.org
BACKGROUND The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[PDF][PDF] Effectiveness of COVID-19 vaccines against the B. 1.617. 2 variant

JL Bernal, N Andrews, C Gower, E Gallagher… - nghianb.org
Background The B. 1.617. 2 COVID-19 variant has contributed to the surge in cases in India
and has now been detected across the globe, including a notable increase in cases in the …

[PDF][PDF] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower, E Gallagher… - vaccine, 2021 - urml-oi.re
BACKGROUND The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[HTML][HTML] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower, E Gallagher… - The New England … - ncbi.nlm.nih.gov
Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[PDF][PDF] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower, E Gallagher… - N Engl J Med, 2021 - fmda.org
BACKGROUND The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[PDF][PDF] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower… - …, 2021 - … .nejmgroup-production.org
BACKGROUND The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …

[PDF][PDF] Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant

JL Bernal, N Andrews, C Gower, E Gallagher… - …, 2021 - areasaludbadajoz.com
BACKGROUND The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19) …